Maeva Olivia Josephine Dhaynaut, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Metabotropic Glutamate | 4 | 2022 | 195 | 0.700 |
Why?
|
| tau Proteins | 5 | 2024 | 2091 | 0.660 |
Why?
|
| Positron-Emission Tomography | 16 | 2024 | 6475 | 0.570 |
Why?
|
| Football | 1 | 2023 | 503 | 0.570 |
Why?
|
| Isoquinolines | 3 | 2024 | 351 | 0.490 |
Why?
|
| Radiopharmaceuticals | 7 | 2024 | 2646 | 0.440 |
Why?
|
| Brain Concussion | 1 | 2023 | 1403 | 0.390 |
Why?
|
| Radioactive Tracers | 2 | 2022 | 66 | 0.390 |
Why?
|
| Alzheimer Disease | 5 | 2024 | 8579 | 0.350 |
Why?
|
| Tauopathies | 2 | 2024 | 320 | 0.300 |
Why?
|
| Potassium Channels | 2 | 2021 | 537 | 0.300 |
Why?
|
| Fluorine Radioisotopes | 2 | 2020 | 418 | 0.280 |
Why?
|
| 4-Aminopyridine | 2 | 2022 | 80 | 0.250 |
Why?
|
| Receptor, Muscarinic M4 | 1 | 2024 | 16 | 0.230 |
Why?
|
| Carbolines | 2 | 2024 | 294 | 0.230 |
Why?
|
| Brain | 13 | 2024 | 27060 | 0.230 |
Why?
|
| Kv1.2 Potassium Channel | 1 | 2022 | 15 | 0.210 |
Why?
|
| Kv1.1 Potassium Channel | 1 | 2022 | 30 | 0.210 |
Why?
|
| Receptors, Opioid, mu | 1 | 2024 | 167 | 0.210 |
Why?
|
| Receptors, Opioid, kappa | 1 | 2024 | 138 | 0.210 |
Why?
|
| Neurodegenerative Diseases | 2 | 2024 | 1084 | 0.200 |
Why?
|
| Microglia | 2 | 2022 | 1357 | 0.200 |
Why?
|
| Macaca mulatta | 3 | 2024 | 2322 | 0.200 |
Why?
|
| Pyrans | 1 | 2022 | 49 | 0.200 |
Why?
|
| Picolinic Acids | 1 | 2022 | 50 | 0.190 |
Why?
|
| Amyloid beta-Peptides | 3 | 2023 | 3835 | 0.180 |
Why?
|
| Cromolyn Sodium | 1 | 2021 | 77 | 0.180 |
Why?
|
| Placebo Effect | 1 | 2024 | 518 | 0.180 |
Why?
|
| Demyelinating Diseases | 1 | 2022 | 351 | 0.170 |
Why?
|
| Entorhinal Cortex | 1 | 2022 | 287 | 0.170 |
Why?
|
| Autoradiography | 1 | 2019 | 730 | 0.150 |
Why?
|
| Aminopyridines | 1 | 2020 | 570 | 0.140 |
Why?
|
| Depressive Disorder, Major | 2 | 2024 | 4760 | 0.130 |
Why?
|
| Molecular Imaging | 1 | 2022 | 814 | 0.130 |
Why?
|
| Doxorubicin | 1 | 2022 | 2215 | 0.120 |
Why?
|
| Temporal Lobe | 1 | 2022 | 1690 | 0.110 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2021 | 2008 | 0.100 |
Why?
|
| Pyridines | 1 | 2024 | 2868 | 0.100 |
Why?
|
| Carbon Radioisotopes | 2 | 2024 | 562 | 0.100 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2022 | 8163 | 0.090 |
Why?
|
| Ligands | 3 | 2022 | 3270 | 0.090 |
Why?
|
| Macaca fascicularis | 2 | 2022 | 901 | 0.080 |
Why?
|
| Rats | 5 | 2022 | 23712 | 0.080 |
Why?
|
| Brain Injuries | 1 | 2020 | 2049 | 0.080 |
Why?
|
| Contrast Media | 1 | 2022 | 5310 | 0.080 |
Why?
|
| Stress, Psychological | 1 | 2024 | 4475 | 0.080 |
Why?
|
| Animals | 11 | 2024 | 168253 | 0.070 |
Why?
|
| Male | 11 | 2024 | 360035 | 0.060 |
Why?
|
| Cyclic S-Oxides | 1 | 2024 | 25 | 0.060 |
Why?
|
| Azabicyclo Compounds | 1 | 2024 | 68 | 0.060 |
Why?
|
| Monoamine Oxidase | 1 | 2024 | 180 | 0.050 |
Why?
|
| Allosteric Regulation | 1 | 2024 | 426 | 0.050 |
Why?
|
| Melanins | 1 | 2024 | 289 | 0.050 |
Why?
|
| Radiochemistry | 1 | 2021 | 49 | 0.050 |
Why?
|
| Mitochondria, Heart | 1 | 2022 | 229 | 0.050 |
Why?
|
| Permeability | 1 | 2022 | 721 | 0.050 |
Why?
|
| Cricetulus | 1 | 2022 | 815 | 0.050 |
Why?
|
| Haplorhini | 1 | 2021 | 529 | 0.040 |
Why?
|
| Mice | 3 | 2022 | 81402 | 0.040 |
Why?
|
| Primates | 1 | 2022 | 523 | 0.040 |
Why?
|
| Cricetinae | 1 | 2022 | 2427 | 0.040 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2022 | 677 | 0.040 |
Why?
|
| Middle Aged | 5 | 2024 | 220382 | 0.040 |
Why?
|
| Aniline Compounds | 1 | 2023 | 1069 | 0.040 |
Why?
|
| Corpus Striatum | 1 | 2024 | 1235 | 0.040 |
Why?
|
| Female | 8 | 2024 | 391875 | 0.040 |
Why?
|
| Dopamine | 1 | 2024 | 1603 | 0.040 |
Why?
|
| Tissue Distribution | 1 | 2021 | 2265 | 0.030 |
Why?
|
| Humans | 9 | 2024 | 760437 | 0.030 |
Why?
|
| Adult | 4 | 2024 | 220781 | 0.030 |
Why?
|
| Kinetics | 1 | 2024 | 6377 | 0.030 |
Why?
|
| Blood-Brain Barrier | 1 | 2022 | 1024 | 0.030 |
Why?
|
| Aged | 4 | 2022 | 168840 | 0.030 |
Why?
|
| Phagocytosis | 1 | 2021 | 1536 | 0.030 |
Why?
|
| Neuroprotective Agents | 1 | 2021 | 957 | 0.030 |
Why?
|
| Myocytes, Cardiac | 1 | 2022 | 1666 | 0.030 |
Why?
|
| Neural Pathways | 1 | 2024 | 3049 | 0.030 |
Why?
|
| Cerebrovascular Circulation | 1 | 2023 | 2728 | 0.030 |
Why?
|
| Nerve Net | 1 | 2024 | 2283 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2024 | 12320 | 0.020 |
Why?
|
| Aged, 80 and over | 3 | 2019 | 58859 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2021 | 5105 | 0.020 |
Why?
|
| Cerebral Cortex | 1 | 2024 | 5764 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2019 | 3576 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2024 | 36362 | 0.020 |
Why?
|
| Cell Line | 1 | 2021 | 15598 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2024 | 9598 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2021 | 18955 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2022 | 18216 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2021 | 22121 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 20078 | 0.010 |
Why?
|
| Young Adult | 1 | 2024 | 59068 | 0.010 |
Why?
|